Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a single-centre, placebo-controlled, randomised, double-blind study to evaluate the safety and tolerability of single ascending doses (SAD) and multiple ascending doses (MAD) of ASLAN003 in healthy subjects
Epistemonikos ID: 7fff0b26a7066195c26ce1daac64461fce63dafd
First added on: May 11, 2024